EUVIMEDEUVIMED entdecken
Crossref

Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background

Suzanne Saffie-Siebert, Imranul Alam iD, Flavia Maria Sutera, Ashkan Dehsorkhi, Nissim Torabi-Pour, Paulina Baran-Rachwalska, Luca Iamartino, Anna Teti, Antonio Maurizi, Rita L Gerard-O'Riley, Dena Acton, Michael J Econs

Calcified Tissue International · 2024

DOI: 10.1007/s00223-024-01222-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Calcified Tissue International, 2024. Verfasst von Suzanne Saffie-Siebert und 11 weiteren Autor:innen. Beteiligte Einrichtung: SiSaf Ltd, Guildford, Surrey, GU2 7RE, UK. saffie@sisaf.com. Hauptthemen laut MEDLINE: Chloride Channels, Osteopetrosis, RNA, Small Interfering, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: SiSaf Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autosomal dominant osteopetrosis type 2 (ADO2) is a rare inherited bone disorder characterised by dense but brittle bones. It displays striking phenotypic variability, with the most severe symptoms, including blindness and bone marrow failure. Disease management largely relies on symptomatic treatment since there is no safe and effective treatment. Most ADO2 cases are caused by heterozygous loss-of-function mutations in the CLCN7 gene, which encodes an essential Cl-/H+ antiporter for proper bone resorption by osteoclasts. Thus, siRNA-mediated silencing of the mutant allele is a promising therapeutic approach, but targeting bone for first-in-human translation remains challenging. Here, we demonstrate the utility of silicon-stabilised hybrid lipid nanoparticles (sshLNPs) as a next-generation nucleic acid nanocarrier capable of delivering allele-specific siRNA to bone. Using a Clcn7G213R knock-in mouse model recapitulating one of the most common human ADO2 mutations and based on the 129S genetic background (which produces the most severe disease phenotype amongst current models), we show substantial knockdown of the mutant allele in femur when siRNA targeting the pathogenic variant is delivered by sshLNPs. We observed lower areal bone mineral density in femur and reduced trabecular thickness in femur and tibia, when siRNA-loaded sshLNPs were administered subcutaneously (representing the most relevant administration route for clinical adoption and patient adherence). Importantly, sshLNPs have improved stability over conventional LNPs and enable 'post hoc loading' for point-of-care formulation. The treatment was well tolerated, suggesting that sshLNP-enabled gene therapy might allow successful clinical translation of essential new treatments for ADO2 and potentially other rare genetic bone diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chloride ChannelsOsteopetrosisRNA, Small InterferingNanoparticlesPhenotypeAllelesAnimalsMiceBone and BonesDisease Models, Animal

Stichwörter der Autor:innen

Autosomal dominant osteopetrosisGene therapySilicon-stabilised hybrid lipid nanoparticlessiRNA

Substanzen

Chloride ChannelsRNA, Small InterferingClcn7 protein, mouse

Autor:innen und Institutionen

  • SiSaf Ltd, Guildford, Surrey, GU2 7RE, UK. saffie@sisaf.com.
  • Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. ialam@iu.edu.
  • SiSaf Ltd, Guildford, Surrey, GU2 7RE, UK.
  • Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100, L'Aquila, Italy.
  • Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
  • Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.

ORCID-Profile: Imranul Alam

Förderung

  • SiSaf Ltd.

Zitieren

APA

Saffie-Siebert, S., Alam, I., Sutera, F. M., Dehsorkhi, A., Torabi-Pour, N., Baran-Rachwalska, P., Iamartino, L., Teti, A., Maurizi, A., Gerard-O'Riley, R. L., Acton, D., & Econs, M. J. (2024). Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background. Calcified Tissue International. https://doi.org/10.1007/s00223-024-01222-3

Vancouver

Saffie-Siebert S, Alam I, Sutera FM, Dehsorkhi A, Torabi-Pour N, Baran-Rachwalska P, et al. Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background. Calcified Tissue International. 2024. doi:10.1007/s00223-024-01222-3

BibTeX
@article{SaffieSiebert2024,
  author = {Saffie-Siebert, Suzanne and Alam, Imranul and Sutera, Flavia Maria and Dehsorkhi, Ashkan and Torabi-Pour, Nissim and Baran-Rachwalska, Paulina and Iamartino, Luca and Teti, Anna and Maurizi, Antonio and Gerard-O'Riley, Rita L and Acton, Dena and Econs, Michael J},
  title = {Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background},
  journal = {Calcified Tissue International},
  year = {2024},
  doi = {10.1007/s00223-024-01222-3}
}
Kostenlos starten →